跳至主要内容
临床试验/TCTR20170905001
TCTR20170905001已完成4 期

Comparison of an automated thermodynamic treatment system (LipiFlow ®) and eyelid warm compress for the treatment of meibomian gland dysfunction

Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 30 人开始时间: 2017年9月5日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • patients at least 18 years of age who had moderate severity of meibomian gland obstruction, defined as a Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire scores of 6-12 or lipid layer thickness (LLT) scores of 40-70 ICU (Interferometric Color Units), measured by using LipiView® (TearScience Inc., Morrisville, NC) or a meibomian gland score of 0-2 from Meibography® (Oculus, Wetzlar, Germany) or the number of expressible meibomian glands (EMG) yielding secretion of 3-6 glands of the lower eyelid.

排除标准

  • patients with systemic diseases resulting in dry eyes such as systemic lupus erythematosus, rheumatoid arthritis, allergic diseases, etc., patients who had eyelid abnormalities, previous ocular surgery or trauma, and patients who used systemic medication affecting dry eyes such as antihistamines, tetracycline derivatives, isotretinoin and topical cyclosporine A or steroid within 1 month.

研究者

发起方
Faculty of Medicine Siriraj Hospital, Mahidol University

相似试验

Comparison of an automated thermodynamic treatment... | 临床试验